Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 117321
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.117321
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.117321
Table 3 Commonly used drugs and their applications
| Name of drug | Primary role | Machine | Clinical application | Study |
| Rifaximin | Regulates intestinal flora and reduces endotoxins | Inhibits the growth of harmful bacteria | Irritable bowel syndrome, hepatic encephalopathy | Improved cognitive function and reduced relapse rates |
| Ursodeoxycholic acid | Protects liver cells and improves bile flow | Reduces bile acid toxicity | Primary biliary cirrhosis | Slowing disease progression and improving survival |
| Probiotic preparation | Regulates the balance of intestinal flora and protects the liver | Increases beneficial bacteria and reduces inflammatory response | Non-alcoholic fatty liver disease, cirrhosis | Improve liver function and reduce fat content |
- Citation: Kang NS, Fang HJ, Zheng SH. Gut-liver axis management and its surgical application: A perspective from “liver governing free flow”. World J Gastrointest Surg 2026; 18(5): 117321
- URL: https://www.wjgnet.com/1948-9366/full/v18/i5/117321.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i5.117321